Whitehawk Therapeutics Investor Relations Material
Latest events
Q4 2024
Whitehawk Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Whitehawk Therapeutics Inc.
Access all reports
Aadi Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers and other serious diseases. The company's lead product is designed to target specific mutations in the mTOR pathway, a key regulator of cell growth and survival. The company is headquartered in Pacific Palisades, California, and its shares are listed on the NASDAQ.
Key slides for Whitehawk Therapeutics Inc.
Investor Update
Whitehawk Therapeutics Inc.
Investor Update
Whitehawk Therapeutics Inc.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
WHWK
Country
🇺🇸 United States